
    
      Subjects will receive testosterone for 4 weeks. Based on a single morning testosterone
      measurement performed at the end of Week 1, the dosage can be titrated up or down to the next
      dose level to maintain testosterone levels in the normal range. At the end of 4 weeks of
      treatment, a pharmacokinetic profile for total testosterone and metabolites will be obtained.
    
  